Working with BD Diagnostics to develop diagnostic test for Parkinson's.
Currently trading below a dime.
Potential annual market is $500,000,000.
Dr. Joseph Rubinfeld, one of the co-founders of Amgen, is on the company's advisory board.
BDX is the partner
Bought in Friday! Thank You Looking to get 1 Million shares for under $40K
Becton will likely buyout AMBS at some point in time. It's a great fit, in the case the partnership bears fruit.
Potential $500,000,000 annual market.